Cite
Xu Z, Lin S, Tong Z, et al. Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model. J Ethnopharmacol. 2021;285:114873doi: 10.1016/j.jep.2021.114873.
Xu, Z., Lin, S., Tong, Z., Chen, S., Cao, Y., Li, Q., Jiang, Y., Cai, W., Tong, Y., Zahra, B. S., & Wang, P. (2021). Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model. Journal of ethnopharmacology, 285114873. https://doi.org/10.1016/j.jep.2021.114873
Xu, Zijin, et al. "Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model." Journal of ethnopharmacology vol. 285 (2021): 114873. doi: https://doi.org/10.1016/j.jep.2021.114873
Xu Z, Lin S, Tong Z, Chen S, Cao Y, Li Q, Jiang Y, Cai W, Tong Y, Zahra BS, Wang P. Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model. J Ethnopharmacol. 2021 Nov 27;285:114873. doi: 10.1016/j.jep.2021.114873. Epub 2021 Nov 27. PMID: 34848360.
Copy
Download .nbib